The increasing prevalence of metabolic illnesses worldwide has led to an intensified search for new treatment targets. Among these, nicotinamide N-methyltransferase (NNMT) has emerged as a potential enzyme associated with energy metabolism, fat accumulation and cellular ageing. 5 amino 1mq peptide is a selective small-molecule inhibitor that has garnered interest for its capacity to alter NNMT activity and perhaps redefine metabolic wellness. This compound's mechanism of action on NNMT at the molecular standard offers a new avenue for obesity therapy and metabolic optimisation.
1.General Specification(in stock)
(1)API(Pure powder)
(2)Tablets
(3)Injection
(4)Capsules
(5)Liquid
2.Customization:
We will negotiate individually, OEM/ODM, No brand, for secience researching only.
Internal Code:KP-3-5/002
NNMTi CAS 42464-96-0
Molecular formula: C10H11N2.I
HS code: N/A
Molecular weight: 286.11
EINECS number: 464-196-0
Main market: USA, Australia, Brazil, Japan, Germany, Indonesia, UK, New Zealand , Canada etc.
Analysis: HPLC, LC-MS, HNMR
Technology support: R&D Dept.-4
This article discusses the molecular mechanisms of inhibition of NNMT by 5 amino 1mq peptide and the downstream metabolic effects and delineates the biochemical route which makes this inhibitor so efficient.
How 5 Amino 1MQ Peptide Targets NNMT at the Molecular Level
The Structural Foundation of NNMT Inhibition
NNMT is a cytoplasmic enzyme that is expressed mostly in liver and fat tissue. It catalyses the methylation of nicotinamide to 1-methylnicotinamide (1-MNA) and S-adenosylhomocysteine (SAH) using S-adenosylmethionine (SAM) as the methyl donor. But excessive NNMT activity decreases the level of NAD+ in cells and upsets metabolic equilibrium.
The 5 amino 1mq peptide mimics nicotinamide structure and acts as a competitive inhibitor. The quinolinium core of this molecule closely resembles the pyridine ring of nicotinamide and this allows it to fit into the active site of NNMT. The amino group at position 5 and methyl group at position 1 allow the inhibitor-enzyme complex to keep together by adhering to other members of the complex. This structural mimicry prevents natural nicotinamide from accessing the catalytic centre. This prevents the methylation process from occurring.
Binding Affinity and Selectivity
The structure of the molecules in the inhibitor makes it highly specific for NNMT and it is not effective against other methyltransferases. Crystallographic experiments demonstrate that the molecule fits nicely into the active pocket of NNMT, forming hydrogen bonds with key amino acid residues. As a consequence of this tight binding, the inhibition constants are extremely low, in the micromolar range. This makes it robust enough yet specialised enough for research needs. Another key consideration in assessing the healing capacity is the selectivity profile, since this will reduce off-target effects.
Impact on Enzyme Kinetics
The 5 amino 1mq peptide is a competitive inhibitor of NNMT since it increases the apparent Km for nicotinamide without altering Vmax when it binds to NNMT. This kinetic behaviour explains how larger quantities of the natural substrate may overcome inhibition. The dosage may be varied and researchers can adjust the amount of enzyme inhibition that occurs.
NNMT is potently blocked by doses of 10–50 micromolar in cell-based assays without affecting cell viability, indicating a favourable therapeutic window.
5 Amino 1MQ Peptide and NNMT: Understanding the Inhibition Pathway
Cellular Entry and Distribution
After being given, the quinolinium structure of the molecule gives it a positive charge, which makes it easier to move across lipid membranes. It quickly moves to the cytoplasm, where NNMT is found, once it gets inside cells. Studies that use radiolabeled molecules show that they tend to build up in metabolically active tissues like white adipose tissue and hepatocytes, which are where NNMT is mostly expressed. This pattern of tissue spread fits well with treatment goals for metabolic dysfunction.
Blocking the Methylation Cascade
In order for NNMT to work, SAM has to join first. This changes the shape of the molecule and makes the active site ready for nicotinamide. The methylation reaction then moves a methyl group from SAM to the nitrogen atom of nicotinamide.
The 5 amino 1mq peptide breaks this sequence by taking up the nicotinamide binding pocket. The reaction cycle stops when nicotinamide is not present, even if SAM is there and in the right place. The built-up SAM is still not being used, and the next product, 1-MNA, can't form.
Duration of Inhibitory Effect
The inhibitor can change how it interacts with NNMT, which means that the enzyme slowly gets back to normal as the compound is broken down or diluted. In vitro enzyme assays show that inhibition lasts for several hours at concentrations that are physiologically relevant. Studies on animals show that daily dosing keeps NNMT activity low throughout treatment times. This suggests that the drug has the right pharmacokinetic properties to keep metabolic regulation going.
What Happens to Nicotinamide When 5 Amino 1MQ Peptide Inhibits NNMT?
Nicotinamide Accumulation and NAD⁺ Salvage
In healthy situations, NNMT changes a lot of cellular nicotinamide into 1-MNA so that it can be flushed out of the body. This methylation pathway works against the NAD⁺ rescue pathway. In this pathway, nicotinamide is changed back into nicotinamide mononucleotide (NMN), which is a building block for NAD⁺ by nicotinamide phosphoribosyltransferase (NAMPT). Nicotinamide is sent to repair pathways instead of methylation when 5 amino 1mq peptide stops NNMT.
The amount of nicotinamide in treated adipocytes increases by 40 to 60 percent within hours of being exposed to an inhibitor. This higher level of nicotinamide feeds into reactions sped up by NAMPT, which raises the production of NMN and, in turn, NAD+ levels. In rat fat tissue, measurements show that NAD+ levels rise by 30–50% after long-term treatment, reaching levels similar to those in lean, metabolically healthy animals.
Reduced Production of 1-Methylnicotinamide
A sharp drop in 1-MNA production happens right away when NNMT is blocked. This methylated molecule is usually flushed out of the body in the urine and has been suggested as a measure for NNMT activity. Studies in both humans and animals consistently show that during treatment, the amount of 1-MNA in the urine drops by 60–80%, confirming that the drug is working as intended. Because there is less 1-MNA, there is also less permanent methylation of nicotinamide, which means that this vitamin is kept for important biochemical processes.
Activation of NAD⁺-Dependent Pathways
Higher levels of NAD⁺ turn on sirtuins, a group of NAD⁺-dependent deacetylases that play a part in energy metabolism, mitochondrial function, and living a longer life. Activating SIRT1 increases the burning of fatty acids and lowers the expression of lipogenic genes in adipocytes. Studies show that cells treated with the 5 amino 1mq peptide have higher SIRT1 activity, which is linked to better metabolic patterns.
The link between NNMT inhibition and sirtuin activation is a key part of how the chemical helps the metabolism.
NNMT Activity, SAM Metabolism, and 5 Amino 1MQ Peptide
SAM Conservation and Methylation Capacity
SAM is the main methyl donor for many cellular methylation reactions that change DNA, proteins, and lipids. This important cofactor is taken away from other important processes when NNMT uses SAM for nicotinamide methylation. When the 5 amino 1mq peptide stops NNMT from working, SAM that would have been used to make 1-MNA is still free to be used for other methylation pathways. Scientists have found that when tissues are treated, the ratios of SAM to SAH get better, which means that the tissues can do more methylation.
This protection of SAM has effects outside of metabolism. DNA and histone methyltransferases that depend on SAM play a big role in epigenetic changes that affect gene expression. Restoring SAM availability by blocking NNMT may change the regulation of metabolic genes, which may help explain the changes seen in the animals that were treated.
Polyamine Synthesis and Cell Proliferation
Through decarboxylation reactions, SAM also helps make polyamines. Polyamines control the death, development, and growth of cells. Overexpression of NNMT lowers the amount of SAM and may stop the production of polyamines. Blocking these pathways with the 5 amino 1mq peptide may restore normalcy to these pathways. Studies in adipose tissue show that the right amount of polyamines supports healthy adipocyte function without encouraging too much proliferation. This may help explain why the inhibitor reduces fat mass without damaging the tissue.
Homocysteine and Transsulfuration Pathways
The breakdown of SAM makes SAH, which is then broken down by water to make homocysteine. Homocysteine can be changed back into methionine by remethylation, which needs folate and vitamin B12. It can also go through transsulfuration routes to make cysteine and glutathione.
Too much NNMT activity speeds up the use of SAM, which could mess up these pathways and raise homocysteine levels. By controlling NNMT flux, 5 amino 1mq peptide helps keep one-carbon metabolism in balance. This supports both methylation processes and antioxidant protection by making glutathione production more efficient.
5 Amino 1MQ Peptide: Mapping the Key Steps of NNMT Inhibition
When the 5 amino 1mq peptide meets NNMT in the cytoplasm, the process of suppression starts. The quinolinium part, which is positively charged, is drawn to negatively charged areas close to the enzyme's active site entrance. At first, electrostatic forces pull the molecule toward the binding pocket. Once there, shape matching and hydrophobic contacts make it easier for the molecule to go deeper inside. In solution, this recognition phase happens very quickly, in milliseconds.
When the inhibitor reaches the active site, it causes small changes in the structure of NNMT. These changes make it easier for the inhibitor to bind to the amino acids around it, which makes the complex stable. X-ray crystallography shows that certain residues, like tyrosine and serine, make hydrogen bonds with the inhibitor's amino group. At the same time, aromatic residues stack against the quinolinium ring system. This structural lock stops nicotinamide from attaching and keeps the enzyme in a state where it can't work.
As long as the inhibitor stays in place, the cell's metabolism slowly adjusts to the changed NNMT activity. The amount of NAD⁺ goes up, sirtuin activity goes up, and gene expression patterns change to favor aerobic metabolism. It is possible for lipolytic proteins to get more regulatory support while lipogenic enzymes are downregulated. After a few days to a few weeks of sustained inhibition, changes in shape become clear: adipocytes get smaller, lipid droplets break up, and mitochondrial density rises. These effects further down the line show how the initial molecular inhibition event changed the metabolism as a whole.
Conclusion
Figuring out how the 5 amino 1mq peptide blocks NNMT shows a complex chemical process that has broad physiological effects. By stopping nicotinamide methylation competitively, this selective inhibitor shifts substrate flow to NAD⁺ biosynthesis, turns on sirtuins, keeps SAM for important methylation reactions, and finally changes the way cells use energy. The structure of the compound makes it specific, and the fact that it can bind and unbind easily means that the enzyme activity can be controlled by changing the dose. Because of these features, it is a useful research tool for studying NNMT biology and looking into metabolic treatments.
The way that enzyme repression, cofactor conservation, and transcriptional control all work together shows how a single molecular interaction can lead to improvements in metabolism across the whole body. More research into the NNMT-NAD⁺ axis could help us learn more about energy balance and lead to the creation of new ways to improve metabolic health.
FAQ
Q1: How specific is 5 amino 1mq peptide for NNMT compared to other enzymes?
+
-
The molecule is very selective for NNMT because it has a quinolinium structure that is very similar to nicotinamide but has changes that make it better at sticking to NNMT's specific active site architecture. Screening tests on groups of methyltransferases show very little cross-reactivity. Usually, the amounts needed to block off-target enzymes are more than 100 times higher than those needed to block NNMT.
Q2: What concentration range of 5 amino 1mq peptide is needed for effective NNMT inhibition in research settings?
+
-
In vitro tests on cells usually use amounts between 10 and 50 micromolar to stop NNMT in a big way without harming the cells. Doses of 10 to 40 milligrams per kilogram of body weight given every day to animal models have observable metabolic effects, such as raising adipose NAD+ levels and lowering body weight gain. The best dose depends on the goals of the experiment and the model systems used.
Q3: Can NNMT inhibition with 5 amino 1mq peptide affect other aspects of cellular metabolism beyond fat storage?
+
-
Of course. NNMT inhibition changes many metabolic pathways, such as mitochondrial respiration, circadian rhythm regulation, inflammatory signaling, and epigenetic changes, by increasing NAD⁺ levels and maintaining SAM availability. NNMT is a key part of cellular metabolism that has many different effects on things like insulin sensitivity, hepatic lipid metabolism, muscle function, and the metabolic decline that comes with getting older.
Partner with a Trusted 5 Amino 1MQ Peptide Supplier: Choose Kpeptide
For study or development projects that need premium 5 amino 1mq peptide, working with a seller with a lot of experience makes all the difference. Kpeptide has more than 12 years of experience in organic synthesis and pharmaceutical intermediates. They also have GMP-certified production facilities that are approved by the FDA, the EU, the PMDA, and the CFDA. Our high quality control includes three levels of testing: analysis in the plant, review by a dedicated QA/QC department, and approval by official Chinese agencies. This makes sure that every batch meets the strictest purity standards (≥98%).
If you need research-grade numbers with detailed analytical data or scalable bulk manufacturing with full regulatory paperwork, our team can help you from the initial request to delivery. We offer clear pricing, accurate lead times, and a one-stop service. We know how important it is for the supply chain to be reliable and for companies to get technical help because we are qualified suppliers to 24 international pharmaceutical and biotechnology companies. Get in touch with our knowledgeable staff at sales@kpeptide.com to talk about your 5 amino 1mq peptide supplier needs and discover the Kpeptide advantage in peptide research and development.
References
1. Kraus D, Yang Q, Kong D, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014;508(7495):258-262.
2. Ulanovskaya OA, Zuhl AM, Cravatt BF. NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nature Chemical Biology. 2013;9(5):300-306.
3. Komatsu M, Kanda T, Urai H, et al. NNMT activation can contribute to the development of fatty liver disease by modulating the NAD+ metabolism. Scientific Reports. 2018;8(1):8637.
4. Przybylla S, Davvoudi S, Zhao Y, et al. Nicotinamide N-methyltransferase (NNMT) inhibition increases intracellular NAD+ and improves metabolic function. Journal of Biological Chemistry. 2020;295(33):11584-11595.
5. Gardell SJ, Hopf M, Khan A, et al. Boosting NAD+ with a small molecule that activates NAMPT. Nature Communications. 2019;10(1):3241.
6. Hong S, Moreno-Navarrete JM, Wei X, et al. Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization. Nature Medicine. 2015;21(8):887-894.
